Kestra Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Kestra Advisory Services's EW Position: Q3 2026 in Review
Kestra Advisory Services increased its Edwards Lifesciences (EW) stake by 40% in Q3 2026, buying an estimated $631K and bringing the position to 24,779 shares worth $2.14M. The position accounts for 0.01% of the portfolio, ranked #1416.
Kestra Advisory Services first reported a position in EW in Q3 2020 and has held it in 25 quarters since. The position peaked at $3.02M in Q4 2022. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Kestra Advisory Services held 24,779 shares of Edwards Lifesciences worth $2.14M as of Q3 2026.
- Kestra Advisory Services bought 7,095 Edwards Lifesciences shares in Q3 2026, an estimated $631K.
- Edwards Lifesciences made up 0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #1416 holding.
- Kestra Advisory Services first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 25 quarters since.
- Kestra Advisory Services's Edwards Lifesciences position peaked at $3.02M in Q4 2022.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.